شرکت‌سرم‌سازی‌شهیدقاضی‌تبریز

دقاضی | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 24,040 1.78
Close Price: 23,520

Income Statement

2026/07/07
Fiscal Year 2026/03/2012 Month
2025/05/07
Fiscal Year 2025/03/2012 Month
2024/05/08
Fiscal Year 2024/03/1912 Month

Revenue from Services & Sales

36.71 Trillion20.984 Trillion16.076 Trillion

Total Revenues

36.71 Trillion20.984 Trillion16.076 Trillion

Cost of Goods Sold

14.032 Trillion9.382 Trillion7.166 Trillion

Gross Profit

22.678 Trillion11.602 Trillion8.91 Trillion

General & Administrative Expenses

1.368 Trillion924.555 Billion666.119 Billion

Net Operating Income & Expenses

587.374 Billion275.129 Billion230.984 Billion

Operating Profit (Loss)

21.898 Trillion10.953 Trillion8.475 Trillion

Profit Before Tax

19.519 Trillion9.977 Trillion7.89 Trillion

Tax

3.688 Trillion1.529 Trillion1.867 Trillion

Net Profit (Loss) After Tax

15.832 Trillion8.448 Trillion6.023 Trillion

Retained Earnings at Beginning of Period

9.275 Trillion6.544 Trillion4.896 Trillion

Approved Dividends — Prior Year AGM

-5.934 Trillion-4.216 Trillion-4.406 Trillion

Capital Decrease (Increase) from Accumulated Losses (Retained Earnings)

--1.5 Trillion-

Allocable Profit

19.173 Trillion9.275 Trillion6.513 Trillion

Legal Reserve

791.584 Billion--

Approved Dividends — Current Year

10.026 Trillion5.934 Trillion4.216 Trillion

Retained Earnings at End of Period

8.355 Trillion3.341 Trillion2.297 Trillion